Drug discovery for overcoming chronic kidney disease (CKD): New therapy for CKD by a (pro)renin-receptor-blocking decoy peptide

Journal of Pharmacological Sciences

Volumn 109, Issue 1, 2009, Pages 20-23

  Ichihara, Atsuhiro ^a   Sakoda, Mariyo ^a   Kurauchi Mito, Asako ^a   Narita, Tatsuya ^a   Kinouchi, Kenichiro ^a   Itoh, Hiroshi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin; Chronic kidney disease (CKD); Diabetes; Hypertension; Mitogen activated protein kinase; Renin

Indexed keywords

ANGIOTENSIN II; HANDLE REGION PEPTIDE; PEPTIDE DERIVATIVE; PRORENIN; PRORENIN RECEPTOR; RENIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; DRUG RECEPTOR BINDING; GLOMERULOSCLEROSIS; HUMAN; HYPERTENSION; HYPERTROPHY; KIDNEY ISCHEMIA; NEPHROSCLEROSIS; NONHUMAN; PLASMA RENIN ACTIVITY; PROTEINURIA; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 58649120513     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.08R07FM     Document Type: Short Survey

References (30)

1. Nguyen G, Delarue F, Burckle C, Bouzhir L, Giller T, Sraer J-D. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest. 2002; 109:1417-1427.
2. Huang Y, Wongamorntham S, Kasting J, McQuillan D, Owens RT, Yu L, et al. Renin increases mesangial cell transforming growth factor-b1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int. 2006;69: 105-113.
3. Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M, Itoh H. The (pro)renin receptor and the kidney. Semin Nephrol. 2007;27: 524-528.
4. Saris J, 'tHoen P, Garrelds I, Dekkers D, denDunnen J, Lamers J, et al. Prorenin induces intracellular signaling in cardiomyocytes independently of angiotensin II. Hypertension. 2006;48:564-571.
5. Huang Y, Noble N, Zhang J, Xu C, Border W. Rerun-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells. Kidney Int. 2007;72:42-52.
6. Sakoda M, Ichihara A, Kaneshiro Y, Takemitsu T, Nakazato Y, Migita T, et al. (Pro)renin receptor-mediated activation of mitogen-activated protein kinases in human vascular smooth muscle cells. Hyper Res. 2007;30:1139-1146.
7. Nabi AHMN, Kageshima A, Uddin M, Nakagawa T, Park E, Suzuki F. Binding properties of rat prorenin and renin to the recombinant rat renin/prorenin receptor prepared by a baculovirus expression system. Int J Mol Med. 2006;18:483-488.
8. Suzuki F, Hayakawa M, Nakagawa T, Nasir UM, Ebihara A, Iwasawa A, et al. Human prorenin has "gate and handle" regions for its non-proteolytic activation. J Biol Chem. 2003;278:22217-22222.
9. Nabi AHMN, Uddin M, Nakagawa T, Iwata H, Ichihara A, Inagami T, et al. Role of "handle" region of prorenin prosegment in the non-proteolytic activation of prorenin by binding to membrane anchored (pro)renin receptor. Front Biosci. 2007;12: 4810-4817.
10. Nguyen G, Danser AHJ. A renin summit: why do we need it? JRAAS. 2008;9:S1-S12.
11. Ichihara A, Sakoda M, Kurauchi-Mito A, Kaneshiro Y, Itoh H. Involvement of (pro)renin receptor in the glomerular filtration barrier. J Mol Med. 2008;86:629-635.
12. Batenburg WW, Krop MK, Garrelds IM, deVries R, deBruin RJA, Burckle CA, et al. Prorenin is the endogenous agonist of the (pro)renin receptor. Binding kinetics of renin and prorenin in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor. J Hypertens. 2007;25:2441-2453.
13. Feldt S, Batenburg WW, Mazak I, Maschke U, Wellner M, Kvakan H, et al. Prorenin and renin-induced extracellular signal regulated kinase 1 /2 activation in monocytes is not blocked by aliskiren or the handle-region peptide. Hypertension. 2008;51:682-688.
14. Nguyen G. Renin/prorenin receptors. Kidney Int. 2006;69: 1503-1506.
15. Derkx F, Schalekamp M. Human prorenin: pathophysiology and clinical implications. Clin Exp Hypertens. 1988;A10:1213-1225.
16. Deinum J, Ronn B, Mathiesen E, Derkx FHM, Hop WCJ, Schalekamp MADH. Increase in serum prorenin precedes onset of microalbuminuria in patients with insulin-dependent diabetes mellitus. Diabetologia. 1999;42:1006-1010.
17. Wilson D, Leutscher JA. Plasma prorenin activity and complications in children with insulin-dependent diabetes mellitus. N Engl J Med. 1990;323:1101-1106.
18. Ichihara A, Hayashi M, Kaneshiro Y, Suzuki F, Nakagawa T, Tada Y, et al. Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for non-proteolytic activation of prorenin. J Clin Invest. 2004;114:1128-1135.
19. Siragy HM, Huang J. Renal (pro)renin receptor upregulation in diabetic rats through enhanced angiotensin AT1 receptor and NADPH oxidase activity. Exp Physiol. 2008;93:709-714.
20. Ichihara A, Suzuki F, Nakagawa T, Kaneshiro Y, Takemitsu T, Sakoda M, et al. Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor deficient mice. J Am Soc Nephrol. 2006;17:1950-1961.
21. Takahashi H, Ichihara A, Kaneshiro Y, Inomata K, Sakoda M, Takemitsu T, et al. Regression of nephropathy developed in diabetes by (pro)renin receptor blockade. J Am Soc Nephrol. 2007;18:2054-2061.
22. Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M, Nakagawa T, Nishiyama A, et al. Contribution of non-proteolytically activated prorenin in glomeruli to hypertensive renal damage. J Am Soc Nephrol. 2006;17:2495-2503.
23. Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M, Suzuki F, Nakagawa T, et al. Non-proteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension. 2006;47:894-900.
24. Susic D, Zhou X, Frohlich ED, Lippton H, Knight M. Cardiovascular effects of prorenin blockade in genetically hypertensive rats (SHR) on normal and high salt diet. Am J Physiol Heart Circ Physiol. 2008;295:H1117-H1121.
25. Susic D, Lippton H, Knight M, Frohlich ED. Cardiovascular effects of nonproteolytic activation of prorenin. Hypertension. 2006;48:e113.
26. Feldt S, Maschke U, Dechend R, Luft FC, Muller DN. Theputative (pro)renin receptor blocker HRP fails to prevent (pro)renin signaling. J Am Soc Nephrol. 2008;19:743-748.
27. Schefe J, Menk M, Reinemund J, Effertz K, Hobbs R, Pandolfi P, et al. A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein. Circ Res. 2006;99:1355-1366.
28. Krebs C, Hamming I, Sadaghiani S, Steinmetz OM, Meyer-Schwesinger C, Fehr S, et al. Antihypertensive therapy upregu-lates renin and (pro)renin receptor in the clipped kidney of Goldblatt hypertensive rats. Kidney Int. 2007;72:725-730.
29. Muller DN, Klanke B, Feldt S, Cordasic N, Hartner A Schmieder RE, et al. (Pro)renin receptor peptide inhibitor "handle-region" peptide does not affect hypertensive nephroscle- rosis in Goldblatt rats. Hypertension. 2008;51:676-681.
30. Nangaku M, Eckardt KU. Hypoxia and the HIF system in kidney disease. J Mol Med. 2007;85:1325-1330.